Built on its long-standing reputation as a leading blood screening systems provider, Bio-Rad’s IH-500 blood typing system is considered a gold standard in immunohematology labs, offering the ...

OncoCyte Corporation’s OCX share price has surged by 12.22%, which has investors questioning if this is right time to sell.

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly.